A review of heterogeneity in attention deficit/hyperactivity disorder (ADHD)

Y Luo, D Weibman, JM Halperin, X Li - Frontiers in human …, 2019 - frontiersin.org
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects
approximately 8%–12% of children worldwide. Throughout an individual's lifetime, ADHD …

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)

OJ Storebø, MRO Storm, JP Ribeiro… - Cochrane Database …, 2023 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is one of the most commonly
diagnosed and treated psychiatric disorders in childhood. Typically, children and …

[HTML][HTML] Systematic reviews of animal models: methodology versus epistemology

R Greek, A Menache - International journal of medical sciences, 2013 - ncbi.nlm.nih.gov
Systematic reviews are currently favored methods of evaluating research in order to reach
conclusions regarding medical practice. The need for such reviews is necessitated by the …

Placebo effects and their determinants in gastrointestinal disorders

S Elsenbruch, P Enck - Nature reviews gastroenterology & hepatology, 2015 - nature.com
Placebo effects in clinical trials have sparked an interest in the placebo phenomenon, both
in randomized controlled trials (RCTs) and in experimental gastroenterology. RCTs have …

Biomarkers in the diagnosis of ADHD–promising directions

SV Faraone, C Bonvicini, C Scassellati - Current psychiatry reports, 2014 - Springer
The etiology and pathogenesis of attention-deficit/hyperactivity disorder (ADHD) are unclear
and a more valid diagnosis would certainly be welcomed. Starting from the literature, we …

Insights into multimodal imaging classification of ADHD

JB Colby, JD Rudie, JA Brown, PK Douglas… - Frontiers in systems …, 2012 - frontiersin.org
Attention deficit hyperactivity disorder (ADHD) currently is diagnosed in children by
clinicians via subjective ADHD-specific behavioral instruments and by reports from the …

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

D Coghill, T Banaschewski, A Zuddas, A Pelaz… - BMC psychiatry, 2013 - Springer
Background The stimulant methylphenidate (MPH) has been a mainstay of treatment for
attention-deficit/hyperactivity disorder (ADHD) for many years. Owing to the short half-life …

Effects of methylphenidate on sleep functioning in children with attention-deficit/hyperactivity disorder

SP Becker, TE Froehlich, JN Epstein - Journal of Developmental …, 2016 - journals.lww.com
Objective: To examine the effects of stimulant medication on the sleep functioning of children
with attention-deficit/hyperactivity disorder (ADHD) and identify predictors of sleep problems …

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

M Huss, P Duhan, P Gandhi, CW Chen… - Neuropsychiatric …, 2017 - Taylor & Francis
Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder characterized
by hyperactivity and/or inattention and is often associated with a substantial impact on …

Pharmacogenomic testing in child and adolescent psychiatry: an evidence-based review

AM Wehry, L Ramsey, SE Dulemba… - Current problems in …, 2018 - Elsevier
Significant advances have been made in the application of pharmacogenomic testing for the
treatment of patients with psychiatric disorders. Over the past decade, a number of studies …